Page last updated: 2024-09-03

rasagiline and Bradykinesia

rasagiline has been researched along with Bradykinesia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buck, PO; Silver, DE1
Rabey, JM; Stocchi, F1
Conner, JB; Griffith, A; Salzman, PM; Seeberger, LC; Silver, D; Wilson, RE1
Christine, CW; Marks, WJ; Ostrem, JL1
Bhat, V; Weiner, WJ1
Cohen, S; Levy, R; Speiser, Z1

Reviews

2 review(s) available for rasagiline and Bradykinesia

ArticleYear
Determining the efficacy of rasagiline in reducing bradykinesia among Parkinson's disease patients: a review.
    The International journal of neuroscience, 2011, Volume: 121, Issue:9

    Topics: Databases, Factual; Humans; Hypokinesia; Indans; Neuroprotective Agents; Parkinson Disease

2011
Parkinson's disease. Diagnosis and the initiation of therapy.
    Minerva medica, 2005, Volume: 96, Issue:3

    Topics: Antioxidants; Diagnosis, Differential; Dopamine Agonists; Humans; Hypokinesia; Indans; Levodopa; Muscle Rigidity; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Selegiline; Tremor

2005

Trials

2 trial(s) available for rasagiline and Bradykinesia

ArticleYear
Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
    European journal of neurology, 2011, Volume: 18, Issue:12

    Topics: Aged; Antiparkinson Agents; Catechols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dysarthria; Facial Expression; Female; Humans; Hypokinesia; Indans; Levodopa; Male; Middle Aged; Monoamine Oxidase Inhibitors; Motor Activity; Muscle Rigidity; Nitriles; Parkinson Disease; Severity of Illness Index; Tremor

2011
Rasagiline: time to onset of antiparkinson effect is similar when used as a monotherapy or adjunct treatment.
    The neurologist, 2011, Volume: 17, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Drug Therapy, Combination; Female; Humans; Hypokinesia; Indans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Prospective Studies; Time Factors

2011

Other Studies

2 other study(ies) available for rasagiline and Bradykinesia

ArticleYear
Development of Parkinson's disease in patients with Narcolepsy.
    Journal of neural transmission (Vienna, Austria : 1996), 2012, Volume: 119, Issue:6

    Topics: Adult; Age of Onset; Antiparkinson Agents; Cataplexy; Central Nervous System Stimulants; Deep Brain Stimulation; Dextroamphetamine; Female; Humans; Hypokinesia; Indans; International Classification of Diseases; Levodopa; Male; Middle Aged; Narcolepsy; Neuroprotective Agents; Parkinson Disease; Sleep; Young Adult

2012
Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.
    Journal of neural transmission. Supplementum, 1998, Volume: 52

    Topics: Aging; alpha-Methyltyrosine; Animals; Avoidance Learning; Catalepsy; Cognition; Cognition Disorders; Haloperidol; Hypokinesia; Hypoxia; Indans; Male; Memory; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Motor Activity; Rats; Rats, Wistar

1998